Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
暂无分享,去创建一个
R. Landewé | J. Smolen | J. Bijlsma | M. Cutolo | J. Smolen | J. Gómez-Reino | J. Gómez-Reino | M. Kouloumas | S. Gorter | R. Landewé
[1] Laure Gossec,et al. Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis , 2010, Annals of the rheumatic diseases.
[2] John Wong,et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs , 2010, Annals of the rheumatic diseases.
[3] Sanjay Sharma. LEVELS OF EVIDENCE , 2007 .
[4] M. Boers,et al. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases , 2009, Annals of the rheumatic diseases.
[5] S SmolenJosef,et al. EULAR (欧州リウマチ学会) 合成および疾患修飾性抗リウマチ生物学的製剤による関節リウマチ管理に関する推奨ガイドライン | 文献情報 | J-GLOBAL 科学技術総合リンクセンター , 2010 .
[6] J. Jacobs,et al. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis , 2008, Annals of the rheumatic diseases.
[7] F. Buttgereit,et al. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial , 2008, The Lancet.
[8] I. Cuthill,et al. Effect size, confidence interval and statistical significance: a practical guide for biologists , 2007, Biological reviews of the Cambridge Philosophical Society.
[9] M. Boers,et al. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. , 2007, The Cochrane database of systematic reviews.
[10] L. Klareskog,et al. Randomized withdrawal of long‐term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density , 2007, Scandinavian journal of rheumatology.
[11] J. Jacobs,et al. Are Glucocorticoids DMARDs? , 2006, Annals of the New York Academy of Sciences.
[12] R. Rau,et al. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. , 2005, Arthritis and rheumatism.
[13] A. Boonen,et al. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. , 2005, Arthritis and rheumatism.
[14] B. Dijkmans,et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. , 2005, Arthritis and rheumatism.
[15] E. Keystone,et al. Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction? , 2005, Arthritis and rheumatism.
[16] G. Kingsley,et al. A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs , 2005, Annals of the rheumatic diseases.
[17] J. Bijlsma,et al. The effect of methylprednisolone pulse therapy on methotrexate treatment of rheumatoid arthritis , 1993, Clinical Rheumatology.
[18] R. Madhok,et al. Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial , 2004, Annals of the rheumatic diseases.
[19] Thomas R. Riley,et al. A Randomized Double-blind Placebo-controlled Trial , 2004 .
[20] P. Gøtzsche,et al. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 2005, The Cochrane database of systematic reviews.
[21] M. Dougados,et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide , 2002, Annals of the rheumatic diseases.
[22] Rene Westhovens,et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. , 2002, Arthritis and rheumatism.
[23] J. Jacobs,et al. Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2002, Annals of Internal Medicine.
[24] P. Gøtzsche,et al. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 2001, The Cochrane database of systematic reviews.
[25] M. Suarez‐Almazor,et al. Moderate-term, low-dose corticosteroids for rheumatoid arthritis. , 1998, The Cochrane database of systematic reviews.
[26] J. Pødenphant,et al. A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects , 1999, Annals of the rheumatic diseases.
[27] P. Hannonen,et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial , 1999, The Lancet.
[28] S. van der Linden,et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis , 1997, The Lancet.
[29] R. Hällgren,et al. The timing of glucocorticoid administration in rheumatoid arthritis , 1997, Annals of the rheumatic diseases.
[30] J. Kirwan,et al. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. , 1995, The New England journal of medicine.
[31] L. V. D. van de Putte,et al. Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trial. , 1995, British journal of rheumatology.
[32] B. Hazleman,et al. The timing of prednisolone dosage and its effect on morning stiffness in rheumatoid arthritis. , 1984, Annals of the rheumatic diseases.
[33] A. Newberg,et al. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. , 1983, The Journal of rheumatology.